The phrase "a compound for which" is correct and usable in written English.
It can be used when referring to a specific compound in a context where you are explaining its purpose, function, or characteristics.
Example: "The researchers developed a compound for which the primary application is in cancer treatment."
Alternatives: "a compound that" or "a compound designed for".
If you have a compound for which you would like to synthesize analogs to improve potency, bioavailability, or toxicity, contact Shi-Xian Deng in the Organic Chemistry Collaborative Center.
Thus, the proposed model can estimate the AIT of a compound for which its AIT is as yet not readily available within a reasonable accuracy.
Indeed, it is difficult to obtain funds to study the concentration-toxicity relationship or a drug-drug interaction for a compound for which the patent has expired.
At the investigated site, where other attenuation processes such as sorption and volatilisation were proven to be negligible, the combined approach is recommended for benzene, which represents a compound for which the effect of biodegradation is comparable to or less than the effect of dilution.
For example, oral dosing of nanosuspensions is commonly used to increase the bioavailability of a compound for which absorption is controlled by dissolution rate without the addition of a large amount of organic co-solvents.
Nitrosodimethylamine (NDMA), a compound for which the detection limit using standard analytical methods is relatively high, required additional remediation at sites when more sensitive analytical methods were employed (Mitch et al. 2003).
Formally, a QSAR model can predict the target property for any compound for which chemical descriptors can be calculated.
The PBDE case study was developed to provide an example of a persistent compound for which relatively few data are available for human exposure, biomonitoring, and health outcomes.
In the evaluation of similarity in the context of orphan drug evaluation, the CHMP needs to decide whether or not an active compound for which a new medicine, or an extension of an existing marketing authorisation (change of indication or line extension), is being sought is similar to an existing orphan drug that has already been authorised.
In addition to the Blind Test results, validation studies for 15 organic molecules are presented, including ethane, ethylene, acetylene, methanol, urea, acetic acid, cyclohexane-1,4-dione, paracetamol, previous Blind Test molecules I to VI and a pharmaceutical compound for which crystal structures have been predicted in a blind test fashion.
At least one analogue should be hypothesized to be an outlier, a ringer, in the category that is, expected to be a target compound for which the read-across from the source compound will be clearly not acceptable.
